Unilever’s Failed Bid Puts Pressure On GSK Spin-Out Plans

Bid Saw UK Pharma Major’s Shares Rise

GSK Skyline
GSK will now press ahead with its spin-out plan, unless another buyer emerges with a higher bid. • Source: Alamy

More from Business

More from Scrip